Skip to main content

Want a detailed portfolio tracker?

IN8bio (INAB) P/E (2021 - 2026)

IN8bio (INAB) P/E from Jul 30, 2021 to Jul 21, 2026. The TTM IN8bio (INAB) P/E is -0.40. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of IN8bio (INAB)

YearP/EChange
2026-0.40-20.87%
2025-0.50+21.61%
2024-0.41-67.08%
2023-1.26-80.94%
2022-6.60-92.86%
2021-92.50N/A

Comparison IN8bio (INAB) P/E with competitors

IN8bio (INAB) P/E is -0.40.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.43%
NBYStablecoin Development Corp0.00-101.08%
ENLVEnlivex Ltd0.07-118.76%
FGENFibroGen Inc0.24-160.20%
CHRSCoherus Biosciences Inc0.85-312.79%
FBIOFortress Biotech Inc0.95-338.00%
ORMPOramed Pharmaceuticals Inc1.50-476.94%
AGENAgenus Inc3.01-854.75%
INVAInnoviva Inc3.15-890.96%
VXRTVaxart Inc3.55-990.20%
CRMDCorMedix Inc3.63-1009.94%
CVACCureVac N.V.4.45-1214.88%
GLPGGalapagos NV4.86-1318.51%
SRPTSarepta Therapeutics Inc4.88-1324.33%
ABEOAbeona Therapeutics Inc5.39-1451.07%
ABUSArbutus Biopharma Corp5.60-1503.26%
ZVRAZevra Therapeutics Inc5.89-1576.39%
SPROSpero Therapeutics Inc6.23-1661.96%
CGENCompugen Ltd6.31-1683.40%
RIGLRigel Pharmaceuticals6.87-1823.37%
SLXNSilexion Therapeutics Corp7.30-1929.70%
OMEROmeros Corporation9.26-2421.90%
AUPHAurinia Pharmaceuticals Inc9.58-2503.71%
PLXProtalix BioTherapeutics Inc10.89-2831.24%
ACADAcadia Pharmaceuticals Inc11.73-3041.27%
TBPHTheravance Biopharma Inc12.26-3175.09%
ADMAAdma Biologics Inc12.42-3214.22%
HRMYHarmony Biosciences Holdings Inc13.82-3565.82%
SABSSAB Biotherapeutics Inc14.14-3645.07%
NAGENiagen Bioscience Inc14.82-3816.09%
INCYIncyte Corp15.82-4067.98%
REGNRegeneron Pharmaceuticals Inc15.86-4076.53%
PBYIPuma Biotechnology Inc17.32-4442.43%
CPRXCatalyst Pharmaceuticals Inc17.44-4473.43%
EXELExelixis Inc17.54-4498.18%
TGTXTG Therapeutics Inc18.97-4856.31%
MDXGMimedx Group Inc20.55-5254.16%
XOMAXOMA Royalty Corp22.87-5836.66%
ARGXArgen X SE24.30-6193.61%
CTMXCytomX Therapeutics Inc24.82-6324.80%
XOMAOXOMA Royalty Corp25.34-6456.14%
HALOHalozyme Therapeutics Inc25.62-6526.08%
XOMAPXOMA Royalty Corp25.67-6537.72%
VRTXVertex Pharmaceuticals Inc27.99-7120.70%
RPRXRoyalty Pharma plc - Class A28.69-7294.45%
SLNOSoleno Therapeutics Inc29.02-7376.66%
ASNDAscendis Pharma A/S30.09-7645.05%
LGNDLigand Pharmaceuticals Inc - Class B37.91-9607.82%
APLSApellis Pharmaceuticals Inc39.02-9886.00%
BMRNBiomarin Pharmaceutical Inc42.21-10686.16%
KRYSKrystal Biotech Inc45.34-11471.53%
ONCBeiGene Ltd69.54-17539.82%
PHARPharming Group N.V.75.03-18915.42%
TECHBio-Techne Corp101.96-25669.81%
VCELVericel Corp109.92-27666.81%
ALNYAlnylam Pharmaceuticals Inc117.96-29684.08%
GMABGenmab140.29-35283.06%
TLXTelix Pharmaceuticals Ltd162.15-40765.78%
CORTCorcept Therapeutics Inc212.86-53481.84%